Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites
about
The functional diversity of protein lysine methylationSerine 216 phosphorylation of estrogen receptor α in neutrophils: migration and infiltration into the mouse uterusRegulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1Minireview: progress and challenges in proteomics data management, sharing, and integrationBiosensors paving the way to understanding the interaction between cadmium and the estrogen receptor alphaLabel-Free Quantitation and Mapping of the ErbB2 Tumor Receptor by Multiple Protease Digestion with Data-Dependent (MS1) and Data-Independent (MS2) Acquisitions.Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.Protein modifications as potential biomarkers in breast cancer.Phosphorylation of serine 212 confers novel activity to human estrogen receptor α.Response of adult mouse uterus to early disruption of estrogen receptor-alpha signaling is influenced by Krüppel-like factor 9Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.Liganded and unliganded activation of estrogen receptor and hormone replacement therapies.A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancerPeptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.Post-translational modifications of nuclear receptors and human diseasePhosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion.Estrogen signaling and cardiovascular disease.Derailed estrogen signaling and breast cancer: an authentic couple.pRb controls estrogen receptor alpha protein stability and activity.Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.Modulation of transcription factor function by O-GlcNAc modification.Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers.Estrogens, Neuroinflammation, and Neurodegeneration.Impact of phosphoproteomics in the translation of kinase-targeted therapies.17β-estradiol regulates estrogen receptor α monoubiquitination.LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.Systematic analysis of human lysine acetylation proteins and accurate prediction of human lysine acetylation through bi-relative adapted binomial score Bayes feature representation.ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors.ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progression.Detection and Functional Analysis of Estrogen Receptor α Phosphorylated at Serine 216 in Mouse Neutrophils.
P2860
Q26853164-A6418B4C-96F2-4300-B628-EEBF91D63F98Q28538001-C1532592-E7FD-48CE-896B-01C4411B72ADQ28569016-6B201AD4-56A9-4900-AA54-56572988252EQ28727478-53868B5F-B72D-4B09-AAE8-44DDE953CBA7Q28741877-FBD9F523-9017-4384-B6BA-567EA0C0EC68Q30633756-D442D9D1-5064-4C53-ABB8-55DE91B89C47Q33521519-91B2E69E-94C7-4C51-B4C1-B2A241CD078EQ33586407-098E182B-1525-4FE4-A40B-9DB81FA994C3Q33662026-CF5BFEB3-E1B6-4C12-817E-6E19A35BB826Q34275465-EE069FDA-1255-4168-9330-42E2A1D19811Q34579904-0B9487A6-8F3F-4330-9923-1C139F861F97Q35062217-1E33B394-4501-49F1-9739-26145EDF35DAQ35555115-A2043E1D-58D2-4C8B-9DC6-44365FC9A346Q35662252-6045B987-6FBF-44FE-934C-CA15077F4936Q35842790-62180D4D-4725-4AB7-A1CF-C19795C0FDB8Q35943932-558123BA-BF54-420C-BEE6-32AA37773797Q35946502-23B427AE-C503-4AC9-85F8-01E1E36695EDQ36099354-F0F852A2-8118-4D36-9B09-A88CA3F8122BQ36589361-4F2A2115-C677-4670-8413-5859159271B1Q37132236-893BEAED-ED62-4A9C-B9AD-41A0847534FBQ37274658-B6A4A7D5-8A70-4FC4-857A-57316BF757B7Q37357416-8B7847B0-AA5A-4729-B624-4A8C7BCBE436Q37632309-395046D5-0D41-4B85-A9BC-703CDDE63043Q37702525-E4FA8BFC-40F4-4DD7-8542-B3988CB20BD1Q38719192-85D4CD23-BE66-4CB2-BB54-227DA1F01116Q38838452-82A8C6CE-2744-4D29-8D39-9455E87C7B3FQ38989188-6B25F03B-9D29-4542-AD0A-967D692065C7Q39600401-C085A0EA-66CC-4AA5-9DC8-D68267697F9EQ42489900-8BD59C19-B79B-4025-9D53-9CE1E3186D7EQ43810829-35F4D421-7AC2-4BE2-ADE4-0A40FCC805A4Q46148692-80EA6291-D201-4F06-BA1D-C261AC300673Q47291460-E61082F3-57CA-4010-A1AF-E5C3C15B055BQ48338119-7C009A7A-2C96-405D-8DD9-515C60E92B1CQ50548776-B5411B40-C5D2-4543-A415-A194FE20FD53
P2860
Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Systematic mapping of posttran ...... on novel phosphorylation sites
@ast
Systematic mapping of posttran ...... on novel phosphorylation sites
@en
type
label
Systematic mapping of posttran ...... on novel phosphorylation sites
@ast
Systematic mapping of posttran ...... on novel phosphorylation sites
@en
prefLabel
Systematic mapping of posttran ...... on novel phosphorylation sites
@ast
Systematic mapping of posttran ...... on novel phosphorylation sites
@en
P2093
P2860
P1476
Systematic mapping of posttran ...... on novel phosphorylation sites
@en
P2093
Birgit Schilling
Bradford W Gibson
Christian Atsriku
Christopher C Benz
David J Britton
Gary K Scott
Michael A Baldwin
P2860
P304
P356
10.1074/MCP.M800282-MCP200
P577
2008-11-03T00:00:00Z